Open Access<p>BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT<sup>®</sup></p>
Author(s) -
Francesco Patti,
María Luisa Martínez Ginés,
Christiane Norenberg,
Fernando Duarte Caron
Publication year - 2020
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s245955
Subject(s) - medicine , prospective cohort study , cohort , observational study , clinically isolated syndrome , interferon beta , multiple sclerosis , immunology
Patients with multiple sclerosis (MS) would benefit from continued long-term treatment with disease-modifying therapies, and autoinjectors may help improve patients' satisfaction with therapy, thereby increasing adherence rates. BETACONNECT ® is an autoinjector for interferon beta-1b designed to improve the injection experience for patients. The BetaEval Global study assessed medication intake in patients using BETACONNECT to further investigate the value of this autoinjector.